AUTL
HEALTHCAREAutolus Therapeutics Ltd
AI Insight
What's Moving AUTL Today?
No stock-specific AI insight has been generated for AUTL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.18$2.70
$1.66
Fundamentals
Market Cap$397M
P/E Ratio—
EPS$-1.09
Dividend Yield—
Dividend / Share—
ROE-29.6%
Profit Margin—
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding266.1M
AUTL News
23 articles- Autolus Therapeutics PLC (AUTL) Earnings Forecast: Future EPS & Revenue Growth EstimatesTradingKey·Jun 18, 2026
- Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue BuildsYahoo Finance·Jun 17, 2026
- European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday TradingYahoo Finance·Jun 16, 2026
- European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for WeekYahoo Finance·Jun 12, 2026
- Autolus Therapeutics Receives Prix Galien UK AwardGlobeNewswire Inc.·Jun 12, 2026
- European Equities Traded in US as ADRs Rise in Thursday TradingYahoo Finance·Jun 11, 2026
- Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock NowYahoo Finance·Jun 10, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday TradingYahoo Finance·Jun 8, 2026
- How The Autolus Therapeutics (AUTL) Investment Story Is Evolving With A Steady Analyst OutlookYahoo Finance·Jun 5, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for WeekYahoo Finance·Jun 5, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Jun 4, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday TradingYahoo Finance·Jun 3, 2026
- Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy?Yahoo Finance·Jun 1, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Lower ThursdayYahoo Finance·May 28, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Wednesday TradingYahoo Finance·May 27, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday TradingYahoo Finance·May 22, 2026
- Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026Yahoo Finance·May 21, 2026
- European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday TradingYahoo Finance·May 21, 2026
- European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday TradingYahoo Finance·May 19, 2026
- European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday TradingYahoo Finance·May 18, 2026
- Autolus Therapeutics PLC (AUTL) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...Yahoo Finance·May 14, 2026
- Autolus (Nasdaq: AUTL) grows AUCATZYL sales and cuts costs in Q1 2026Stock Titan·May 14, 2026
- Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesGlobeNewswire Inc.·Mar 27, 2026
All 23 articles loaded
Price Data
Open$1.48
Previous Close$1.49
Day High$1.67
Day Low$1.48
52 Week High$2.70
52 Week Low$1.18
52-Week Range
$1.18$2.70
$1.66
Fundamentals
Market Cap$397M
P/E Ratio—
EPS$-1.09
Dividend Yield—
Dividend / Share—
ROE-29.6%
Profit Margin—
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding266.1M
About Autolus Therapeutics Ltd
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T-cell therapies for the treatment of cancer. The company is headquartered in London, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—